Cargando…

Recent advances in precision medicine for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Although advances in systemic chemotherapy for PDAC have improved survival outcomes for patients with the disease, chemoresistance is a major treatment issue for unselected PDAC patient populations. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Hiromitsu, Higashi, Takaaki, Miyata, Tatsunori, Yamashita, Yo‐ichi, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316748/ https://www.ncbi.nlm.nih.gov/pubmed/34337294 http://dx.doi.org/10.1002/ags3.12436

Ejemplares similares

Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy
por: Yamamura, Kensuke, et al.
Publicado: (2022)

Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma
por: Matsumura, Kazuki, et al.
Publicado: (2022)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Risk factors for lymph node metastasis in patients with pancreatic neuroendocrine neoplasms
por: Nakao, Yosuke, et al.
Publicado: (2022)

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
por: Liu, Zhao, et al.
Publicado: (2023)

Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1
por: Sonoda, Akari, et al.
Publicado: (2020)

A case of successful transarterial stenting for pseudoaneurysm after pancreaticoduodenectomy
por: Kitamura, Fumimasa, et al.
Publicado: (2020)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Frailty and surgical outcomes in gastrointestinal cancer: Integration of geriatric assessment and prehabilitation into surgical practice for vulnerable patients
por: Mima, Kosuke, et al.
Publicado: (2022)

Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy
por: Hayashi, Hiromitsu, et al.
Publicado: (2020)

Colon cancer metastasis mimicking a hilar cholangiocarcinoma: a case report and literature review
por: Ofuchi, Takashi, et al.
Publicado: (2020)

Coexisting schwannoma of the gallbladder and sarcoidosis: a case report
por: Tajiri, Takuya, et al.
Publicado: (2020)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Ectopic hepatocellular carcinoma mimicking a retroperitoneal tumor: A case report
por: Adachi, Yuki, et al.
Publicado: (2020)

Assessment for the minimal invasiveness of laparoscopic liver resection by interleukin-6 and thrombospondin-1
por: Kaida, Takayoshi, et al.
Publicado: (2022)

Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma
por: Yusa, Toshihiko, et al.
Publicado: (2022)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
por: Yang, Xiao-Yan, et al.
Publicado: (2023)

Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
por: Franck, Caspar, et al.
Publicado: (2020)

Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
por: Gerber, Michael H., et al.
Publicado: (2018)

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations
por: Tarabay, Anthony, et al.
Publicado: (2023)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
por: Koga, Yuki, et al.
Publicado: (2018)

Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
por: Montemagno, Christopher, et al.
Publicado: (2021)

Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects
por: Jin, Tianqiang, et al.
Publicado: (2020)

Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients
por: Halle-Smith, James M., et al.
Publicado: (2023)

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
por: Zhang, Joshua, et al.
Publicado: (2023)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
por: Fan, Jia-qiao, et al.
Publicado: (2020)

Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
por: Kruger, Deirdré, et al.
Publicado: (2022)

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions
por: Yamada, Reiko, et al.
Publicado: (2023)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective
por: Peretti, Umberto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bijpuhn0hoq07quo7h6bu6k9hh